What's new in the diagnosis and therapy of eosinophilic esophagitis?

Current Opinion in Gastroenterology

Volumn 25, Issue 4, 2009, Pages 366-371

  Straumann, Alex ^a,c   Hruz, Petr ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NONE   (Switzerland)

Author keywords

Definition; Diagnostic criteria; Endoscopic signs; Eosinophilic esophagitis; Indication for treatment

Indexed keywords

AZATHIOPRINE; BUDESONIDE; EOTAXIN 3; FLUTICASONE; INFLIXIMAB; INTERLEUKIN 5; MEPOLIZUMAB; MERCAPTOPURINE; METHOTREXATE; PLACEBO; PREDNISONE; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE PREDISPOSITION; DRUG EFFICACY; DYSPHAGIA; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS; ESOPHAGUS CANDIDIASIS; GASTROESOPHAGEAL REFLUX; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TREATMENT INDICATION; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ALENDRONATE; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIAL INFECTIONS; EOSINOPHILIA; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 68049087841     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32832ad89d     Document Type: Review

References (44)

1. Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38:109-116.
2. Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994; 124:1419-1429. (Pubitemid 24267319)
3. Vitellas KM, Bennett WF, Bova JG, et al. Idiopathic eosinophilic esophagitis. Radiology 1993; 186:789-793.
4. Furuta GT, Straumann A. Review article: the pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther 2006; 24:173-182. (Pubitemid 43972889)
5. Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83:818-823.
6. Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000; 30:242-244.
7. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133:1342-1363.
8. Straumann A, Spichtin HP, Bucher KA, et al. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion 2004; 70:109-116. (Pubitemid 39370405)
9. Gupta SK, Fitzgerald JF, Chong SK, et al. Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children? Gastrointest Endosc 1997; 45:485-489.
10. Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 2003; 57:407-412.
11. Baxi S, Gupta SK, Swigonski N, et al. Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc 2006; 64:473-478. (Pubitemid 44397068)
12. Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003; 58:516-522. (Pubitemid 37205763)
13. Langdon DE. 'Congenital' esophageal stenosis, corrugated ringed esophagus, and eosinophilic esophagitis. Am J Gastroenterol 2000; 95:2123-2124.
14. Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc 2004; 59:355-361. (Pubitemid 38337841)
15. Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006; 63:3-12. (Pubitemid 41827769)
16. Straumann A, Degen L, Felder S, et al. Budesonide as induction treatment for active eosinophilic esophagitis in adolescents and adults: a randomized, double-blind, placebo-controlled study. Gastroenterology 2008; 134:A-104.
17. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007; 102:1301-1306. (Pubitemid 46802025)
18. Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology 1997; 112:1448-1456.
19. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115:418-419.
20. Ngo P, Furuta GT, Antonioli DA, et al. Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006; 101:1666-1670. (Pubitemid 43980644)
21. Mueller S, Neureiter D, Aigner T, Stolte M. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastrooesophageal reflux disease on oesophageal biopsy material. Histopathology 2008; 53:676-684. This study compares relevant histopathological parameters of EoE and GERD. (Pubitemid 352768719)
22. Bhattacharya B, Carlsten J, Sabo E, et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38:1744-1753. (Pubitemid 350179935)
23. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116:536-547. (Pubitemid 43228372)
24. Collins MH, Blanchard C, Abonia JP, et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol 2008; 6:621-629.
25. Kukuruzovic RH, Elliott EE, O'Loughlin EV, et al. Nonsurgical interventions for eosinophilic oesophagitis. Cochrane Database Syst Rev 2004:CD004065.
26. Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18:99-118. (Pubitemid 350176666)
27. Straumann A, Bussmann C, Zuber M, et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008; 6:598-600. This retrospective study shows an analysis of relevant EoE complications in a large series of adult EoE patients. This report assesses the risk of spontaneously arising and procedure-induced complications and proposes practical recommendations.
28. Aceves SS, Newbury RO, Dohil R, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119:206-212. (Pubitemid 46037819)
29. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003; 125:1660-1669. (Pubitemid 37500430)
30. Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue specific Il-5-induced eosinophilia. Gastroenterology 2008; 134:204-214. Animal model analyzing the mechanisms of eosinophil-induced esophageal remodeling. (Pubitemid 350309313)
31. Liacouras CA, Wenner WJ, Brown K, et al. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26:380-385. (Pubitemid 28160684)
32. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003; 78:830-835. (Pubitemid 36759291)
33. Faubion WA Jr, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27:90-93. (Pubitemid 28293032)
34. Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004; 2:568-575.
35. Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122:1216-1225.
36. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131:1381-1391. (Pubitemid 44780861)
37. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008; 6:165-173. This study compares efficacy and side effects of topical and systemic corticosteroid treatment.
38. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3:1198-1206. (Pubitemid 41797671)
39. Mishra A, Hogan SP, Brandt EB, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002; 168:2464-2469. (Pubitemid 34171851)
40. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118:1312-1319. (Pubitemid 44872890)
41. Straumann A, Conus S, Kita H, et al. Mepolizumab, a humanized monoclonal antibody to IL-5, for severe eosinophilic esophagitis in adults: a randomized, placebo controlled double-blind trial. Gastroenterology 2007; 132:2586.
42. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108:954-961. (Pubitemid 33151548)
43. Straumann A, Bussmann C, Conus S, et al. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol 2008; 122:425-427.
44. Netzer P, Gschossmann JM, Straumann A, et al. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007; 19:865-869. (Pubitemid 47415145)